Paper20445751
Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphoma.
Iurescia S and 7 others. J Biomed Biotechnol, 2010. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphoma. Papers, record 20445751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20445751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphoma.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complementarity Determining Regions | Major topic |
| Lymphoma, B-Cell | Major topic |
| Peptide Fragments | Major topic |
| Tetanus Toxin | Major topic |
| Vaccines, DNA | Major topic |
| Animals | |
| CD8-Positive T-Lymphocytes | |
| Chi-Square Distribution | |
| Electroporation | |
| Flow Cytometry | |
| Interferon-gamma | |
| Kaplan-Meier Estimate | |
| Male | |
| Mice | |
| Mice, Inbred C3H | |
| Xenograft Model Antitumor Assays |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11861263 | Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. | Blood | 2002 | https://conductscience.org/library/papers/11861263 | PubMed |
| 2 | 9129015 | Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial. | Blood | 1997 | https://conductscience.org/library/papers/9129015 | PubMed |
| 3 | 18364239 | Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model. | Biochem Biophys Res Commun | 2008 | https://conductscience.org/library/papers/18364239 | PubMed |
| 4 | 17906339 | Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition. | Int Immunol | 2007 | https://conductscience.org/library/papers/17906339 | PubMed |
| 5 | 17878373 | In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells. | J Immunol | 2007 | https://conductscience.org/library/papers/17878373 | PubMed |
| 6 | 16860659 | Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines. | Adv Cancer Res | 2006 | https://conductscience.org/library/papers/16860659 | PubMed |
| 7 | 10096292 | Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. | Nat Biotechnol | 1999 | https://conductscience.org/library/papers/10096292 | PubMed |
| 8 | 8564842 | Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. | Nat Med | 1996 | https://conductscience.org/library/papers/8564842 | PubMed |
| 9 | 18781156 | DNA vaccines: ready for prime time? | Nat Rev Genet | 2008 | https://conductscience.org/library/papers/18781156 | PubMed |
| 10 | 11718453 | Anti-lymphoma immunity: relative efficacy of peptide and recombinant DNA vaccine. | Cancer Detect Prev | 2001 | https://conductscience.org/library/papers/11718453 | PubMed |
| 11 | 14974761 | Cancer statistics, 2004. | CA Cancer J Clin | 2004 | https://conductscience.org/library/papers/14974761 | PubMed |
| 12 | 8782465 | DNA immunization induces protective immunity against B-cell lymphoma. | Nat Med | 1996 | https://conductscience.org/library/papers/8782465 | PubMed |
| 13 | 15623607 | Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15623607 | PubMed |
| 14 | 11245465 | Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. | Cancer Res | 2001 | https://conductscience.org/library/papers/11245465 | PubMed |
| 15 | 11466377 | DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines. | J Immunol | 2001 | https://conductscience.org/library/papers/11466377 | PubMed |
| 16 | 3498771 | Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. | J Immunol | 1987 | https://conductscience.org/library/papers/3498771 | PubMed |
| 17 | 2481588 | Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. | Eur J Immunol | 1989 | https://conductscience.org/library/papers/2481588 | PubMed |
| 18 | 16827622 | Therapeutic lymphoma vaccines: importance of T-cell immunity. | Expert Rev Vaccines | 2006 | https://conductscience.org/library/papers/16827622 | PubMed |
| 19 | 12477501 | IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. | Dev Comp Immunol | 2003 | https://conductscience.org/library/papers/12477501 | PubMed |
| 20 | 15146248 | Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15146248 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35745675 | Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35745675 | PubMed |
| 30962578 | Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies. | Leukemia | 2019 | https://conductscience.org/library/papers/30962578 | PubMed |
| 23162790 | Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins. | Front Oncol | 2012 | https://conductscience.org/library/papers/23162790 | PubMed |
| 20390416 | DNA vaccination strategies for anti-tumour effective gene therapy protocols. | Cancer Immunol Immunother | 2010 | https://conductscience.org/library/papers/20390416 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CDR3 | 8163 | PubTator's text mining | https://conductscience.org/library/genes/8163 | NCBI Gene |
| CEACAM3 | 1084 | PubTator's text mining | https://conductscience.org/library/genes/1084 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20445751
GET https://conductscience.org/api/papers/v1/20445751/references?page=2